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Abstract
Background: A substantial proportion of patients with whiplash injuries develop chronic
symptoms. However, the best treatment of acute injuries to prevent long-term problems is
uncertain. A stepped care treatment pathway has been proposed, in which patients are given advice
and education at their initial visit to the emergency department (ED), followed by review at three
weeks and physiotherapy for those with persisting symptoms. MINT is a two-stage randomised
controlled trial to evaluate two components of such a pathway: 1. use of The Whiplash Book versus
usual advice when patients first attend the emergency department; 2. referral to physiotherapy
versus reinforcement of advice for patients with continuing symptoms at three weeks.
Methods: Evaluation of the Whiplash Book versus usual advice uses a cluster randomised design
in emergency departments of eight NHS Trusts. Eligible patients are identified by clinicians in
participating emergency departments and are sent a study questionnaire within a week of their ED
attendance. Three thousand participants will be included. Patients with persisting symptoms three
weeks after their ED attendance are eligible to join an individually randomised study of
physiotherapy versus reinforcement of the advice given in ED. Six hundred participants will be
randomised. Follow-up is at 4, 8 and 12 months after their ED attendance. Primary outcome is the
Neck Disability Index (NDI), and secondary outcomes include quality of life and time to return to
work and normal activities. An economic evaluation is being carried out.
Conclusion: This paper describes the protocol and operational aspects of a complex intervention
trial based in NHS emergency and physiotherapy departments, evaluating two components of a
stepped-care approach to the treatment of whiplash injuries. The trial uses two randomisations,
with the first stage being cluster randomised and the second individually randomised.
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Whiplash injuries are a major health and economic prob-
lem around the world. In the UK, their annual cost to the
economy is about £2,553 million (1990 prices), repre-
senting about 18% of the total costs of all road traffic col-
lisions and 0.4% of the Gross Domestic Product[1]. The
costs are caused by absence from work due to injury and
considerable health service costs. Most patients recover
quickly but a substantial proportion, estimated by differ-
ent studies at between 19% and 60%[2,3], may develop
chronic symptoms. These patients generate the majority
of costs, and prevention of chronic symptoms is therefore
a priority in treatment of whiplash injuries.
Definitions of whiplash and associated conditions vary
between published studies. The Quebec Task Force (QTF)
definitions are internationally recognised and are used in
this study[4]. Whiplash is the mechanism of injury (accel-
eration-deceleration injuries usually in the frontal plane),
whiplash injuries are the soft tissue injuries that result and
Whiplash Associated Disorder (WAD) describes the pat-
tern of symptoms that arise (Table 1). A further term, late
whiplash syndrome, is used to describe the chronic com-
plications of whiplash.
Despite whiplash being a common injury, there are few
good quality randomised trials upon which to base rec-
ommendations for practice[5]. In the mid 1990s the QTF
undertook an extensive review and expert consensus exer-
cise[4], and found that there was insufficient evidence
supporting the treatments currently used. They concluded
that promoting activity in the early stages was probably
the most effective strategy, soft collars were not helpful,
and physiotherapy, a very common treatment, required
rigorous evaluation. The QTF proposed a clinical pathway
in which patients are given advice and education at the
initial contact, and then reviewed at three weeks. Patients
with persisting symptoms would then be provided with
more intensive treatment.
A stepped care clinical pathway as proposed by the QTF is
the model evaluated in this trial. The advice and educa-
tion component to be evaluated is The Whiplash Book[6].
This has been developed largely based on the results of a
systematic review[7], which suggested that psychological
risk factors are the strongest predictors of poor outcome in
whiplash patients, and argued that advice to resume nor-
mal activity, using a cognitive-behavioural approach,
should be the treatment of choice for early management.
However, other systematic reviews have suggested that
physical and psychological factors may carry equivalent
amounts of risk for poor outcome[8]. Furthermore, most
of the literature cited to support the early activity and key
health promotion messages was from the field of low back
pain and other chronic conditions. It is questionable
whether these results are transferable to acute whiplash
injuries, as the conditions differ markedly in their causes
and psychological consequences. For example, phobic
travel anxiety and other psychological manifestations of
shock are common after whiplash[9], but rarely occur
with low back pain.
The second component of the stepped care approach eval-
uated in MINT is physiotherapy for patients whose symp-
toms have not resolved by three weeks. Physiotherapy
treatments that are commonly used for whiplash patients
include hot and cold therapy, electrotherapies, mobilisa-
tion, manipulation, exercises of many different kinds, and
traction. There is good quality trial evidence to support
the effectiveness of mobilisation and exercise in the man-
agement of chronic neck pain[10-12], but it is uncertain
whether these treatments are effective for whiplash
patients. The Cochrane review of conservative treatments
for whiplash[4] concluded that there was some evidence
that active treatments are superior to passive, though the
existing trials were not of high quality. Another review
concluded that there was moderate quality evidence that
exercises and mobilisations commonly used by physio-
therapists were effective[13], but this was based on just
three small trials, which reported short-term outcomes
only, did not perform intention to treat analyses, and did
not have blinding of outcome assessment. For evaluation
in MINT we have designed a package of physiotherapy
treatments that, according to current evidence, are those
most likely to be effective in prevention of late whiplash
syndrome and to be acceptable to practitioners.
Table 1: Case definitions of Whiplash Associated Disorders
Term Definition
WAD Grade 0 No neck complaints or signs
WAD Grade I Complaint of pain, stiffness or tenderness, but no physical signs
WAD Grade II Complaint of pain, stiffness or tenderness, and musculo-skeletal signs (decreased range of motion, point tenderness etc)
WAD Grade III Complaint of pain, stiffness or tenderness and neurological signs (decreased or absent deep tendon reflexes, weakness 
and sensory deficits). Could also have musculo-skeletal signs.
WAD Grade IV Fracture or dislocation
Late whiplash syndrome Presence of pain, restriction of motion or other symptoms at six months or more after the injury, sufficient to hinder 
return to normal activities such as driving, usual occupation and leisure.Page 2 of 7
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A national survey of practice in the UK indicated that the
most common treatment for whiplash in emergency
departments (ED) is advice, but the content and quality of
the advice varies [unpublished data]. Over 90% of depart-
ments suggest using analgesics and gradually increasing
movement of the neck. Some departments use soft collars
as well, suggesting that they should be removed and the
neck exercised on a regular basis.
Methods
MINT is a multi-centre randomised controlled trial to esti-
mate the clinical effectiveness of a stepped care approach
to whiplash injuries on clinical outcomes over 12 months,
the effectiveness in pre-specified sub-groups of patients
(those with severe physical symptoms, prior neck prob-
lems, psychological or physical risk factors for poor out-
come, and those seeking compensation), and the costs
and cost-effectiveness of each strategy.
The trial will use two separate randomisations: the first
stage is a cluster randomised trial in which NHS Trusts are
randomised to use the Whiplash Book or give their usual
advice, for all patients presenting with whiplash injuries.
The second stage is individual randomisation to physio-
therapy or the control intervention of a single advice ses-
sion reinforcing the advice given in ED, for patients still
experiencing whiplash symptoms at three weeks. The two
parts of the trial have a common system of follow-up at
four, eight and 12 months.
The trial is being run in 12 NHS Acute Trusts in the UK:
Heart of England NHS Foundation Trust (Heartlands and
Solihull Hospitals), North Bristol NHS Trust (Frenchay
Hospital), Oxford Radcliffe Hospitals NHS Trust (John
Radcliffe Hospital), University Hospitals Coventry and
Warwickshire NHS Trust (Walsgrave Hospital and Hospi-
tal of St Cross, Rugby), Gloucestershire Hospitals NHS
Trust (Cheltenham and Royal Gloucester Hospitals),
South Warwickshire General Hospitals NHS Trust (War-
wick Hospital), Worcestershire Acute Hospitals NHS Trust
(Alexandra Hospital, Redditch), University Hospitals Bir-
mingham NHS Trust (Selly Oak Hospital), Kettering Gen-
eral Hospital NHS Trust (Kettering General Hospital),
Buckinghamshire Hospitals NHS Trust (Stoke Mandeville
Hospital, Countess of Chester Hospital NHS Foundation
Trust (Countess of Chester Hospital), and Gwent Health-
care NHS Trust (Royal Gwent Hospital, Newport). Some
Trusts comprise several hospitals and have more than one
Emergency Department.
Ethics Committee approval
MINT was approved by the Trent Multicentre Research
Ethics Committee and by the Local Research Ethics Com-
mittee and the Research and Development Committee of
each participating centre.
Stage 1: Cluster randomised trial of the whiplash book 
versus usual advice
Inclusion and exclusion criteria
All people who attend ED with a whiplash injury of less
than six weeks duration will be included in the trial,
except those with any of the following exclusion criteria:
1. Age less than 18 years.
2. Fractures or dislocations of the spine or other bones.
3. Head injuries with more than a transient loss of con-
sciousness or with a Glasgow Coma Score of 12 or less at
any stage of their assessment in hospital.
4. Admission to in-patient services.
5. Severe psychiatric illness.
Identifying participants and consent
Because the first part of the trial is cluster randomised,
individual consent for participation is not sought. This is
an accepted procedure for cluster randomised trials where
individuals do not have a choice of whether to receive the
trial intervention[14]. All eligible patients at each partici-
pating hospital are included unless they indicate that they
do not wish to participate in data collection.
Clinicians in ED are responsible for identifying eligible
participants. Details of whiplash patients are recorded on
the trial proforma, a short form developed specifically for
MINT that replaces the normal methods of clinical data
collection in participating centres. It is intended to avoid
duplication of recording of information for clinical and
research purposes, and hence allows collection of a rou-
tine core clinical data set, including injury severity, pain
intensity and WAD grade diagnosis. It contains tick boxes
to ensure that clinicians have provided potential partici-
pants with the trial information sheet and have discussed
the study with them, and also records if the patient would
prefer not to receive the study questionnaires. The pro-
forma is self-copying; one copy is filed in the medical
notes as a treatment record and the second copy is passed
to the research team to notify them that a patient has been
asked to participate. Completed proformas are collected
in a secure place in the ED and forwarded to the MINT
research team twice a week.
Patients are informed about the possibility that they may
be eligible for stage 2 of the study but detailed informa-
tion about this is not given at this stage, as the majority of
patients who participate in stage 1 will not have persistentPage 3 of 7
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stage 2. Patients are also asked for their contact details
(address, phone number, mobile phone and email), to
assist with sending out and following up questionnaires.
Randomisation
The unit of randomisation is the NHS Trust. Participating
Trusts were randomised before the start of recruitment by
the project statisticians, to usual advice or the Whiplash
Book. Trusts were pair matched on size (number of ED
attendances per year), star rating, and ethnic composition
of the surrounding area. We randomised by Trust rather
than by ED to avoid contamination when staff of one
Trust worked in more than one ED. Randomisation used
a table of random numbers, starting at a random place to
ensure that the allocations were not known before ran-
domisation. The allocation depended on whether the next
digit was even or odd. One of each pair was randomised
to the Whiplash Book, and the other member was allo-
cated to usual advice.
Delivery of interventions
Training of ED staff in the trial procedures is given before
the start of recruitment, and there is frequent contact
between the centres and the trial team to identify and
resolve any problems. Eligible patients are given a letter of
introduction about the study, signed by their local ED
consultant, and the study is discussed with them. If they
are willing to participate, they are told that they will
receive a questionnaire in a few days time. They are asked
to return this and to contact the MINT study team if they
continue to have problems after two weeks. The introduc-
tion letter does not mention randomisation of hospitals
to The Whiplash Book or usual advice, but simply states
that the hospital is taking part in a study of advice given to
patients with whiplash injuries. ED clinicians provide a
copy of either the ED's usual advice leaflet or the Whip-
lash Book, and verbal guidance on management of whip-
lash injuries. We have obtained copies of the usual advice
leaflets from all of the EDs participating in MINT, so that
the content of the advice in the control arm can be docu-
mented.
Baseline data collection
All whiplash patients that are eligible for MINT and have
not asked to be excluded are sent a copy of the MINT base-
line questionnaire within a week of their ED attendance.
This includes demographic information and baseline
administration of some of the outcome measures. If the
questionnaire is not returned within a week, participants
are sent a reminder by SMS text message, email or post.
Stage 2: Individually randomised trial of physiotherapy 
versus reinforcement of advice given in ED
Identifying participants and consent
Participants in Stage 1 are asked to contact the study office
if they continue to have symptoms two weeks after their
attendance at ED. An appointment is then made for the
patient with a research physiotherapist based at their local
hospital. At this appointment, their eligibility for Stage 2
of the trial is assessed. If eligible, trial participation is dis-
cussed and the patient is asked to sign a study consent
form prior to randomisation. Information about Stage 2
of MINT is sent to patients several days before their
research clinic appointment, ensuring that they have suf-
ficient time to consider participation.
Inclusion and exclusion criteria
Participants in Stage 1 of MINT are eligible for the second
part of the trial if they:
• Report symptoms in the 24 hours before attendance at
the physiotherapy research clinic approximately three
weeks after attendance at ED
• Are WAD grade I-III at this time
• Do not have any contra-indications to physiotherapy
treatment. These include central cord compression or
upper motor neuron lesion, complete nerve root com-
pression or lower motor neuron lesion, suspected vascular
injury or haemorrhagic event.
Randomisation
Randomisation to physiotherapy or reinforcement of
advice is via a central telephone randomisation service,
based at the Cancer Research Clinical Trials Unit, Univer-
sity of Birmingham. Randomisation is stratified by centre,
to avoid imbalance between centres giving different
advice in ED, and members of the same household are
assigned to the same intervention, to reduce the chance of
contamination. This will be taken into account in the trial
analysis. If eligible patients decline participation, their
reasons for doing so are recorded.
Interventions
All interventions are delivered by physiotherapists who
are independent of the recruitment and randomisation
procedures, and have attended a 1.5 day training session
by the trial team. The same therapists deliver both the
physiotherapy and control interventions, and each treat-
ment session is recorded in a treatment log. A sample of
sessions of both interventions is observed for quality con-
trol purposes. All treatments should be completed within
four months of the patient's first attendance at ED.
(a) PhysiotherapyPage 4 of 7
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package have up to six sessions of therapy, over an eight
week period. The components of the intervention are
described in a training and reference manual. The choice
of physiotherapy treatments has been made using two
principles; first, there is evidence that the treatments are
effective for chronic neck dysfunction and are likely to be
effective for whiplash injuries, based on expert opinion or
limited trial evidence, and second, the treatments target
established and potentially modifiable risk factors for
developing late whiplash syndrome, including reduced
cervical range of motion, high pain intensity, and adverse
psychological reactions to the injury.
Three treatments are included in the physiotherapy pack-
age:
(1) Mobilisation (gentle manipulation) of the cervical
and upper thoracic spine according to Maitland[15].
(2) Exercises for the cervical spine, thoracic spine and
shoulder to improve range of movement and muscle con-
trol.
(3) A cognitive behavioural approach to treatment deliv-
ery, which has been effective in physiotherapy for other
painful conditions[16].
Manipulation (Maitland Grade IV) of the cervical spine is
excluded from this treatment package. Both whiplash
injury and cervical manipulation have the potential to
cause damage to the vertebral artery that may result in a
cerebrovascular event. In common with some, but not all,
authorities we consider that recent trauma is a contraindi-
cation to cervical manipulation.
(b) Reinforcement of advice
Participants randomised to reinforcement of advice
receive a single 40-minute session of advice from a physi-
otherapist. At this session, the physiotherapist re-states
the advice that the patient was given at the time of their
ED attendance (either the Whiplash Book or the hospital's
usual advice), discusses any queries that the patient may
have, and may check the exercises that the patient was
given in ED. The physiotherapist can only give advice
regarding progression of exercises or activities specified in
the Whiplash Book or usual advice. They cannot prescribe
new exercises or use any "hands on" treatment. No review
appointments are offered to these patients. They are
advised to see their GP if they have ongoing problems.
Other treatments
Participants may seek other forms of treatment during the
follow up period from their GP or other health profes-
sionals. If the trial interventions are effective, this should
be evident in a reduction in additional treatments. Such
treatments, including changes in the amount or types of
analgesia used, use of physical treatments (osteopathy,
chiropractic or physiotherapy), alternative therapies, or
referral to secondary care services will be recorded as a
treatment outcome.
Outcome measures and data collection
Follow-up data collection is by postal questionnaire. The
outcome measures are detailed in Table 2. The primary
outcome is return to normal function after the whiplash
injury, measured using the Neck Disability Index (NDI).
The NDI is a self-completed questionnaire that has been
used successfully in a postal format in trials of neck treat-
ments[10,17]. It assesses pain-related activity restrictions
in 10 areas including personal care, lifting, sleeping, driv-
ing, concentration, reading and work. The SF-12 and EQ-
5D are included to assess generic health-related quality of
life, and to enable a single utility score for economic eval-
uation to be derived from the EQ-5D. Participants also
rate whether they have improved, remained the same, or
worsened, and their satisfaction with treatment. Resource
use is assessed by a short questionnaire which asks about
additional NHS or private hospital treatment for the
whiplash injury, any GP consultations, manipulation,
massage or other treatment. Participants are asked to dis-
tinguish between prescription and out-of-pocket
expenses.
Table 2: Outcome measures
Domain Measures* Time points
Function Neck Disability Index 4, 8, 12 months
Time to return to work and normal activities (including driving) 4, 8, 12 months
Health-related quality of life SF12 0, 4, 8, 12 months
Satisfaction 5 point Likert scale 4, 8, 12 months
Economics Resource use questionnaire 0, 4, 8, 12 months
EQ-5D (health utility) 0, 4, 8, 12 months
*all outcome measures are collected by self-completed postal questionnairesPage 5 of 7
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they have pursued and settled a compensation claim
related to their whiplash injury. It is not asked at 4 or 8
month follow-up to avoid stimulation of claims among
the trial population.
A research assistant who has not been involved in the
recruitment or randomisation processes is responsible for
mailing follow up questionnaires, and for entering
responses onto the study database. Blinding of the study
team will be maintained until final analysis of the data
has been completed.
Statistical analysis
The analysis will be by intention to treat. All patients will
be analysed in the groups to which they were randomised,
regardless of the treatment that they actually received. The
two main comparisons will be Whiplash Book versus
usual advice, and physiotherapy package versus reinforce-
ment of ED advice. The comparison of ED advice inter-
ventions will use appropriate methods to take account of
the cluster randomisation[18]. Estimates of treatment
effect with 95% confidence intervals, and the numbers
needed to treat, will be reported. Additional exploratory
analyses will investigate whether there is an interaction
between the ED advice intervention and physiotherapy.
Four pre-specified subgroup analyses will be undertaken:
1. severe physical symptoms at trial entry (WAD Grade III
versus WAD Grade I or II)
2. adverse psychological reactions at trial entry (yes/no)
3. pre-existing neck pain versus no pre-existing neck pain
4. compensation; claim being pursued versus not being
pursued
Statistical tests of interaction will be used to perform sub-
group analyses[19].
Economic analysis will use cost-minimisation, or cost-
effectiveness and cost-utility analysis, depending on the
clinical results. For cost-utility analysis, the EQ-5D will be
used to generate utility scores, which will provide an esti-
mate of the incremental cost of any benefit gained in
terms of improved health status. Decision modelling will
be used to investigate the costs and benefits of the differ-
ent patient management routes, and uncertainty will be
quantified by multi-way sensitivity analyses[20].
Sample size
For the primary outcome of NDI, there is consensus that a
minimal clinically importance difference lies in the range
of 3–5 percentage points, with a standard deviation of
about 8%[8]. We therefore aim to be able to detect a dif-
ference between the groups of three percentage points (i.e.
0.375 standard deviations), both for the comparison of
the Whiplash Book and usual advice, and for physiother-
apy versus reinforcement of advice. For the individually
randomised comparison (physiotherapy versus reinforce-
ment of advice), 211 per group will be required, based on
90% power and 1% significance level. Assuming a worst
case scenario of 30% loss to follow-up gives a total sample
size of 300 per group (600 in total)[21]. The comparison
of ED advice interventions is cluster randomised, so larger
numbers are needed. Originally it was planned that eight
centres would participate, recruiting 4,800 participants.
This was revised with the inclusion of four additional cen-
tres, which allowed reduction of the overall sample size
required to achieve the same power. Assuming an intra-
cluster correlation co-efficient of 0.02, and an average of
120 patients per centre gives an inflation factor of
5.94[22], leading to a sample size of 713 in each group.
Allowing for 30% loss to follow up, 1020 participants per
group will be needed (2040 in total). To allow for a reduc-
tion in power caused by unequal sample sizes among clus-
ters, the target sample size has been set to 3000 (an
average of 250 per cluster). The assumptions underlying
the sample size calculation will be monitored by the
DMEC during recruitment and adjustments may be made
during the course of the trial.
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